REVELATION BIOSCIENCES, INC. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Revelation Biosciences, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Revelation Biosciences, Inc. Assets for the quarter ending September 30, 2024 was $6.74M, a 52.6% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$6.74M	-$7.48M	-52.6%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$12.3M	-$3.77M	-23.5%	Jun 30, 2024	10-Q/A	2024-09-23
Q1 2024	$14.7M	-$3.42M	-18.9%	Mar 31, 2024	10-Q/A	2024-09-23
Q4 2023	$12.2M	+$6.71M	+122%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$14.2M	+$7.62M	+115%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$16M	+$11.9M	+286%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$18.1M	+$10.1M	+127%	Mar 31, 2023	10-Q	2023-05-22
Q4 2022	$5.5M	+$3.46M	+169%	Dec 31, 2022	10-K/A	2024-09-23
Q3 2022	$6.6M	-$67M	-91%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$4.15M	-$69.7M	-94.4%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$7.98M	-$66M	-89.2%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$2.04M	-$72.1M	-97.2%	Dec 31, 2021	10-K	2023-03-30
Q3 2021	$73.6M	+$70.1M	+2002%	Sep 30, 2021	10-Q	2021-10-29
Q2 2021	$73.9M			Jun 30, 2021	10-Q	2021-08-23
Q1 2021	$74M			Mar 31, 2021	10-Q	2021-06-22
Q4 2020	$74.2M	+$74.1M		Dec 31, 2020	10-K	2022-04-15
Q3 2020	$3.5M			Sep 30, 2020	10-Q	2020-11-16
Q4 2019	$22.7K^*			Dec 31, 2019	10-K/A	2021-06-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.